O’bloo: High-Performance Neonatal Phototherapy
Neonatal jaundice is a common condition in newborns, often requiring prompt management to avoid complications. O’bloo by Médipréma has been designed to provide intensive phototherapy treatment, enabling rapid regression of jaundice through simultaneous and uniform exposure of the infant's entire body surface.
The device features 16 blue tubes distributed in two semi-cylindrical hoods, ensuring optimized illumination. The upper hood, mounted on a vertical slide assisted by a cylinder, allows precise adjustment according to clinical needs. The infant is placed on a comfortable hammock, receiving homogeneous treatment while being fully secured by protective screens. Side windows and a removable front screen ensure constant monitoring and easy access.
O’bloo includes a control unit with an LCD screen, enabling precise programming of exposure time and monitoring of operational parameters. A timer records the usage duration of the tubes, which have a maximum lifespan of 2000 hours. To maintain a stable environment, the device is equipped with a ventilation system that keeps the hammock temperature at approximately 33°C ±3°C, with continuous monitoring of the temperature inside the cradle.
In terms of safety, O’bloo features visual and audible alarms to prevent risks of hypothermia or hyperthermia. Its base is mounted on four swivel casters, two with brakes, facilitating movement within hospital departments. An ergonomic handle allows for easy maneuvering. Shelves and a sliding drawer provide practical storage space for accessories and additional equipment.
The integrated pulse oximeter option allows real-time monitoring of oxygen saturation (SpO2) and pulse rate, displayed on the LCD screen with adjustable alarms. This feature enhances the monitoring of newborns undergoing intensive phototherapy.
With its reliable performance and design focused on patient comfort and ease of use for medical staff, O’bloo stands out as essential equipment for the effective treatment of neonatal jaundice in hospital settings.
